'No good evidence' for independent sector treatment centres

There is no good evidence that independent sector treatment centres have provided additional capacity, value for money, or high-quality care, argue researchers in the BMJ.

The policy of the DoH in England is to use NHS funds to contract with for-profit multinational healthcare corporations to deliver clinical services.

Dr Jonathan Fielden, chairman of the BMA's Consultants Committee, said: ‘This paper adds to the criticisms from the Public Accounts Committee and the Healthcare Commission relating to the quality and cost effectiveness of these centres.

‘We have repeatedly raised concerns that this is £5 billion wasted on ideology rather than evidence. The government seems to have been charmed by the private sector, but is unable to prove its effectiveness or value for money.'

neil.durham@haymarket.com

BMJ online

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in